Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference Article

Rahman, Rifaquat, Polley, Mei-Yin C, Alder, Laura et al. (2023). Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference . LANCET ONCOLOGY, 24(4), E161-E171. 10.1016/S1470-2045(23)00005-0

Open Access International Collaboration

cited authors

  • Rahman, Rifaquat; Polley, Mei-Yin C; Alder, Laura; Brastianos, Priscilla K; Anders, Carey K; Tawbi, Hussein A; Mehta, Minesh; Wen, Patrick Y; Geyer, Susan; de Groot, John; Zadeh, Gelareh; Piantadosi, Steven; Galanis, Evanthia; Khasraw, Mustafa

sustainable development goals

authors

publication date

  • April 1, 2023

published in

keywords

  • ANAPLASTIC OLIGODENDROGLIOMA
  • BIOMARKER
  • CANCER
  • CHEMOTHERAPY
  • EXTERNAL CONTROL
  • Life Sciences & Biomedicine
  • Oncology
  • PHASE-III TRIAL
  • RADIATION-THERAPY
  • RADIOTHERAPY
  • SINGLE-ARM
  • Science & Technology
  • TEMOZOLOMIDE

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCIENCE INC

start page

  • E161

end page

  • E171

volume

  • 24

issue

  • 4